Golden has been acquired by ComplyAdvantage.Read about it here ⟶

CASI Pharmaceuticals

CASI is a U.S. NASDAQ-listed biopharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innovative therapeutics in China, the U.S., and throughout the world.

Overview Structured Data Issues Contributors Activity

casipharmaceuticals.com

Is a

Organization

Company

Company attributes

Industry

Engineering

Biomedical engineering

Location

Chaoyang District, Beijing

B2X

B2B

CEO

Wei-Wu He

Pitchbook URL

pitchbook.com/profiles.../40734-19

Legal Name

CASI Pharmaceuticals, Inc.0

Number of Employees (Ranges)

51 – 200

Email Address

hr@casi.cn

ir@casipharmaceuticals.com0

Phone Number

+124086426000

Full Address

1701-1702, China Central Office Tower 1, No.81 Jianguo Road Chaoyang District, Beijing, 100025, China0

9620 Medical Center Drive Suite 300 Rockville, MD 208500

CIK Number

895,0510

Place of Incorporation

Delaware

IRS Number

581,959,4400

Fax Number

(301) 315-24370

86 10 6508 6063 ext 80120

Stock Symbol

CASI0

Exchange

Nasdaq

Patents Assigned (Count)

Country

United States

China

Other attributes

Company Operating Status

Active

Contact Page URL

casipharmaceuticals.com/abo...-us/

Previous Name

ENTREMED INC0

SIC Code

2,8360

Ticker Symbol

CASI

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like CASI Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API